S&P 500   4,688.33 (+2.11%)
DOW   35,742.12 (+1.46%)
QQQ   397.98 (+3.05%)
AAPL   170.93 (+3.39%)
MSFT   334.99 (+2.70%)
FB   324.13 (+1.97%)
GOOGL   2,937.59 (+2.60%)
AMZN   3,540.92 (+3.31%)
TSLA   1,046.28 (+3.69%)
NVDA   321.38 (+6.99%)
BABA   125.53 (+1.56%)
NIO   33.31 (+3.00%)
CGC   10.86 (+7.00%)
AMD   145.54 (+4.66%)
GE   97.93 (+2.00%)
MU   86.55 (+4.97%)
T   23.10 (-0.77%)
F   19.88 (+3.43%)
DIS   150.34 (-0.02%)
PFE   51.51 (+0.06%)
AMC   31.25 (+8.54%)
ACB   6.44 (+7.87%)
BA   210.36 (+2.18%)
S&P 500   4,688.33 (+2.11%)
DOW   35,742.12 (+1.46%)
QQQ   397.98 (+3.05%)
AAPL   170.93 (+3.39%)
MSFT   334.99 (+2.70%)
FB   324.13 (+1.97%)
GOOGL   2,937.59 (+2.60%)
AMZN   3,540.92 (+3.31%)
TSLA   1,046.28 (+3.69%)
NVDA   321.38 (+6.99%)
BABA   125.53 (+1.56%)
NIO   33.31 (+3.00%)
CGC   10.86 (+7.00%)
AMD   145.54 (+4.66%)
GE   97.93 (+2.00%)
MU   86.55 (+4.97%)
T   23.10 (-0.77%)
F   19.88 (+3.43%)
DIS   150.34 (-0.02%)
PFE   51.51 (+0.06%)
AMC   31.25 (+8.54%)
ACB   6.44 (+7.87%)
BA   210.36 (+2.18%)
S&P 500   4,688.33 (+2.11%)
DOW   35,742.12 (+1.46%)
QQQ   397.98 (+3.05%)
AAPL   170.93 (+3.39%)
MSFT   334.99 (+2.70%)
FB   324.13 (+1.97%)
GOOGL   2,937.59 (+2.60%)
AMZN   3,540.92 (+3.31%)
TSLA   1,046.28 (+3.69%)
NVDA   321.38 (+6.99%)
BABA   125.53 (+1.56%)
NIO   33.31 (+3.00%)
CGC   10.86 (+7.00%)
AMD   145.54 (+4.66%)
GE   97.93 (+2.00%)
MU   86.55 (+4.97%)
T   23.10 (-0.77%)
F   19.88 (+3.43%)
DIS   150.34 (-0.02%)
PFE   51.51 (+0.06%)
AMC   31.25 (+8.54%)
ACB   6.44 (+7.87%)
BA   210.36 (+2.18%)
S&P 500   4,688.33 (+2.11%)
DOW   35,742.12 (+1.46%)
QQQ   397.98 (+3.05%)
AAPL   170.93 (+3.39%)
MSFT   334.99 (+2.70%)
FB   324.13 (+1.97%)
GOOGL   2,937.59 (+2.60%)
AMZN   3,540.92 (+3.31%)
TSLA   1,046.28 (+3.69%)
NVDA   321.38 (+6.99%)
BABA   125.53 (+1.56%)
NIO   33.31 (+3.00%)
CGC   10.86 (+7.00%)
AMD   145.54 (+4.66%)
GE   97.93 (+2.00%)
MU   86.55 (+4.97%)
T   23.10 (-0.77%)
F   19.88 (+3.43%)
DIS   150.34 (-0.02%)
PFE   51.51 (+0.06%)
AMC   31.25 (+8.54%)
ACB   6.44 (+7.87%)
BA   210.36 (+2.18%)
OTCMKTS:WDDMF

WeedMD Stock Forecast, Price & News

$0.06
-0.01 (-14.29%)
(As of 12/6/2021 12:00 AM ET)
Add
Compare
Today's Range
$0.06
▼
$0.07
50-Day Range
$0.07
▼
$0.16
52-Week Range
$0.17
▼
$1.00
Volume
1.84 million shs
Average Volume
274,867 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A
View Price History Chart DataSkip Price History Chart
30 days | 90 days | 365 days | Advanced Chart
Receive WDDMF News and Ratings via Email

Sign-up to receive the latest news and ratings for WeedMD and its competitors with MarketBeat's FREE daily newsletter.


WeedMD logo

About WeedMD

Entourage Health Corp. engages in the production and distribution of cannabis products for both the medical and adult-use markets. It focuses on selling directly to medical patients, seniors market, and provincial distribution agencies. The company was founded on July 16, 2014 and is headquartered in Aylmer, Canada.

Headlines

Janet Yellen Says 'Of Course' Cannabis Companies Banking Their Billions Would Help The IRS
December 4, 2021 |  benzinga.com
Entourage Health Announces New Ticker Symbol on U.S.-Based OTCQX Market as ‘ETRGF’ Effective September 1, 2021
September 1, 2021 |  finance.yahoo.com
Peak partners with Boston Beer Company to develop, produce, and distribute cannabis-infused beverages in Canada
August 31, 2021 |  finance.yahoo.com
Entourage Health Partners with Boston Beer Subsidiary to Launch and Sell Portfolio of Innovative Cannabis-Infused Beverages in Canada
August 31, 2021 |  finance.yahoo.com
Entourage Health Expands its Saturday Cannabis Brand into Quebec
August 11, 2021 |  finance.yahoo.com
Entourage Health Reports Q2 Financial Results with $13.8 Million Record Revenue Representing 92% YOY Increase and Third Consecutive Quarter of Growth
August 10, 2021 |  finance.yahoo.com
Cannabis Producer Entourage Health: Preliminary Record Q2 Revenue Of $13.6M After Name Change From WeedMD
July 20, 2021 |  msn.com
Entourage Health Announces Preliminary Record Q2 Revenues of $13.6 Million and Confirms Financial Results Call to be Held on August 10, 2021 at 10 a.m. ET
July 20, 2021 |  finance.yahoo.com
Entourage Health Cannabis Co Shares Will Debut On TSXV Under New Ticker After Rebranding From WeedMD
July 16, 2021 |  benzinga.com
WeedMD Inc. and CannTx Life Sciences Sign Definitive Acquisition Agreement and Confirm Corporate Name as Entourage Health Corp.
July 14, 2021 |  finance.yahoo.com
WeedMD To Rebrand And Become Entourage Health Corp As Part Of Its 'Evolution'
July 6, 2021 |  feeds.benzinga.com
WeedMD Inc. Announces Intent to Change Corporate Name to Entourage Health Corp.
July 5, 2021 |  finance.yahoo.com
WeedMD: 102% Record Increase In Q1 2021 Revenue, Adjusted EBITDA Improves Over $31M Sequentially
June 29, 2021 |  msn.com
See More Headlines

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Drug Manufacturers—Specialty & Generic
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:WDDMF
Previous Symbol
CUSIP
N/A
CIK
N/A
Web
www.weedmd.com
Phone
(844) 933-3636
Fax
N/A
Employees
212
Year Founded
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Price-To-Earnings

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable

MarketRank™

Overall MarketRank™

1.70 out of 5 stars

Analyst Opinion: 3.5Community Rank: 5.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -












WeedMD (OTCMKTS:WDDMF) Frequently Asked Questions

Is WeedMD a buy right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for WeedMD in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" WeedMD stock.
View analyst ratings for WeedMD or view top-rated stocks.

What price target have analysts set for WDDMF?

1 equities research analysts have issued 12-month target prices for WeedMD's stock. Their forecasts range from $0.60 to $0.60. On average, they expect WeedMD's share price to reach $0.60 in the next twelve months. This suggests a possible upside of 900.0% from the stock's current price.
View analysts' price targets for WeedMD or view top-rated stocks among Wall Street analysts.

Who are WeedMD's key executives?

WeedMD's management team includes the following people:
  • George Scorsis, Executive Chairman & Chief Executive Officer
  • Jeff Keyes, Vice President-Operations
  • Beth Carreon, Chief Financial Officer
  • Peter M. Blecher, Chief Medical Officer
  • Jason Alexander, Director & Chief Legal Officer

What is WeedMD's stock symbol?

WeedMD trades on the OTCMKTS under the ticker symbol "WDDMF."

How do I buy shares of WeedMD?

Shares of WDDMF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is WeedMD's stock price today?

One share of WDDMF stock can currently be purchased for approximately $0.06.

How many employees does WeedMD have?

WeedMD employs 212 workers across the globe.

What is WeedMD's official website?

The official website for WeedMD is www.weedmd.com.

Where are WeedMD's headquarters?

WeedMD is headquartered at 250 Elm Street, Aylmer, ON N5H.

How can I contact WeedMD?

WeedMD's mailing address is 250 Elm Street, Aylmer, ON N5H. The company can be reached via phone at (844) 933-3636.


This page was last updated on 12/7/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

Twitter Facebook StockTwits

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.